Inventor
BROWN MILTON L
US35 patents
⚠️ This page may combine multiple inventors who share the name “BROWN MILTON L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV GEORGETOWN
18 patentsUS9303017B2Apr 5, 2016
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof
UNIV GEORGETOWN5 citations71
US11672789B2Jun 13, 2023
Radiation mitigator and method of use thereof
UNIV GEORGETOWN1 citations70
US11311526B2Apr 26, 2022
Radiation mitigator and method of use thereof
UNIV GEORGETOWN2 citations70
US9346784B2May 24, 2016
Phenyl-substituted nicotinic ligands, and methods of use thereof
UNIV GEORGETOWN3 citations69
US10487056B2Nov 26, 2019
Small molecule androgen receptor inhibitors and methods of use thereof
UNIV GEORGETOWN2 citations68
US10173978B2Jan 8, 2019
Small molecule androgen receptor inhibitors and methods of use thereof
UNIV GEORGETOWN1 citations68
US12246011B2Mar 11, 2025
Radiation mitigator and method of use thereof
UNIV GEORGETOWN0 citations59
US11053255B2Jul 6, 2021
Synthesis of mahanine and related compounds
UNIV GEORGETOWN1 citations59
US11104646B2Aug 31, 2021
Small molecule androgen receptor inhibitors and methods of use thereof
UNIV GEORGETOWN0 citations58
US10407406B2Sep 10, 2019
2-halo-5-alkynyl-pyridyl nicotinic ligands
UNIV GEORGETOWN0 citations51
US9890137B2Feb 13, 2018
2-halo-5-alkynyl-pyridyl nicotinic ligands
UNIV GEORGETOWN1 citations51
US9993465B2Jun 12, 2018
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof
UNIV GEORGETOWN1 citations50
US10023551B2Jul 17, 2018
Glutathione-cleavable prodrug and methods of use thereof
UNIV GEORGETOWN0 citations49
US9994548B2Jun 12, 2018
Phenyl-substituted nicotinic ligands, and methods of use thereof
UNIV GEORGETOWN1 citations48
US9889131B2Feb 13, 2018
Cadherin-11 inhibitors and methods of use thereof
UNIV GEORGETOWN1 citations48
US9284368B2Mar 15, 2016
Substituted pyrazines as cadherin-11 inhibitors
UNIV GEORGETOWN1 citations48
US10806725B2Oct 20, 2020
Small molecule inhibitors of XBP1 splicing
UNIV GEORGETOWN0 citations47
US9522908B2Dec 20, 2016
Ezrin inhibitors and methods of making and using
UNIV GEORGETOWN0 citations30
BROWN MILTON L
8 patentsUS8178545B2May 15, 2012
Dual small molecule inhibitors of cancer and angiogenesis
BROWN MILTON L14 citations92
US8816095B2Aug 26, 2014
Na channels, disease, and related assays and compositions
BROWN MILTON L34 citations88
US8642610B2Feb 4, 2014
Dual small molecule inhibitors of cancer and angiogenesis
BROWN MILTON L6 citations83
US9233949B2Jan 12, 2016
Treatment for oxidative stress and/or hypertension
BROWN MILTON L3 citations66
US8298512B2Oct 30, 2012
Methods of determining β-III tubulin expression
BROWN MILTON L2 citations62
US8293513B2Oct 23, 2012
Histone deacetylase inhibitors
BROWN MILTON L4 citations57
US10457639B2Oct 29, 2019
Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
BROWN MILTON L0 citations42
US8729103B2May 20, 2014
Silent desensitizers of neuronal nAChR and methods of use thereof
BROWN MILTON L0 citations39
UNIV VIRGINIA
4 patentsUS7439383B2Oct 21, 2008
Sodium channel blockers
UNIV VIRGINIA2 citations62
US7893071B2Feb 22, 2011
Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
UNIV VIRGINIA1 citations52
US7414078B2Aug 19, 2008
Oral general anesthetics and metabolitically resistant anticonvulsants
UNIV VIRGINIA0 citations52
US7026358B2Apr 11, 2006
Oral general anesthetics and metabolitically resistant anticonvulsants
UNIV VIRGINIA0 citations52